The inclusion criteria for this meta-analysis were as follows: (1) detection of GHET1 expression in human cancers by quantitative real-time PCR (qRT-PCR); (2) patients in the study were divided into subgroups based on different GHET1 expression levels; (3) prognosis or clinicopathological feature of GHET1 was reported; (4) hazard ratios (HRs) and 95% confidence intervals (CI) were able to be obtained directly or indirectly from the article. The gene discussed is GHET1; the disease is cancer.